Pacific Biosciences (PACB) |
|
3.5431 0.023 (0.66%)
|
06-01 12:33 |
|
Open: |
3.55 |
Pre. Close: |
3.52 |
|
High:
|
3.565 |
Low:
|
3.52 |
|
Volume:
|
244,339 |
Market Cap:
|
546M |
|
|
|
|
Pacific Biosciences of California Inc is a biotechnology company. It is engaged in design, development, and manufacture of sequencing system to help scientists resolve genetically complex problems. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
3.572 - 3.596 |
3.596 - 3.615 |
|
Low:
|
3.424 - 3.447 |
3.447 - 3.467 |
|
Close:
|
3.486 - 3.524 |
3.524 - 3.555 |
|
Technical analysis |
as of: 2020-06-01 12:01:11 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 4.44 One year: 5.18 |
| Support: |
Support1: 3.39 Support2: 3.13 |
| Resistance: |
Resistance1: 3.80 Resistance2: 4.44 |
| Pivot: |
3.57 |
| Moving Average: |
MA(5): 3.58 MA(20): 3.51
MA(100): 3.71  MA(250): 4.76 |
| MACD: |
MACD(12,26): 0.08 Signal(9): 0.10 |
| Stochastic oscillator: |
%K(14,3): 51.40 %D(3): 60.45 |
| RSI: |
RSI(14): 53.52 |
| 52-week: |
High: 7.03 Low: 2.20 Change(%): -48.6 |
| Average Vol(K): |
3-Month: 168220 10-Days: 91281 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.PACB has closed above bottom band by 43.5%. Bollinger Bands are 71.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to PACB's normal range. The bands have been in this narrow range for 17 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Thu, 07 May 2020
Pacific Biosciences of California Inc (PACB) Q1 2020 Earnings Call Transcript - Motley Fool
Wed, 06 May 2020
Pacific Biosciences of California, Inc. Announces First Quarter 2020 Financial Results - GlobeNewswire
Fri, 08 May 2020
Pacific Biosciences (PACB) Q1 Earnings Surpass Estimates - Yahoo Finance
Mon, 18 May 2020
Pacific Biosciences of California Inc. (PACB) Soars 3.02% on May 18 - Equities.com
Wed, 27 May 2020
Market Analysts see Pacific Biosciences of California Inc. [PACB] gaining to $5. Time to buy? - The DBT News
Mon, 11 May 2020
Pacific Biosciences of California Inc. [PACB] Stock trading around $3.39 per share: What’s Next? - The DBT News
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Diagnostics Research |
| Shares Out. (M) |
154 |
| Shares Float (M) |
150 |
|
% Held by Insiders
|
4.33 |
|
% Held by Institutions
|
87.94 |
|
Shares Short (K)
|
17,890 |
|
Shares Short P. Month (K)
|
18,350 |
Stock Financials |
|
EPS
|
-0.343 |
|
EPS Est This Year
|
-0.890 |
|
EPS Est Next Year
|
-0.640 |
|
Book Value (p.s.)
|
0.390 |
|
Profit Margin
|
-58.35 |
|
Operating Margin
|
-92.18 |
|
Return on Assets (ttm)
|
-24.7 |
|
Return on Equity (ttm)
|
-67.7 |
|
Qtrly Rev. Growth
|
-5.0 |
|
Gross Profit (p.s.)
|
0.224 |
|
Sales Per Share
|
0.585 |
|
EBITDA (p.s.)
|
-0.493 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
22 |
|
Levered Free Cash Flow (M)
|
76 |
Stock Valuations |
|
PE Ratio
|
-10.35 |
|
PEG Ratio
|
|
|
Price to Book value
|
9.10 |
|
Price to Sales
|
6.07 |
|
Price to Cash Flow
|
24.46 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
